510(k) device
RIVOS EUS Access Device (M00553900)
Boston Scientific Corporation · Endoscopic Ultrasound System, Gastroenterology-Urology (ODG, Class II) · First FDA decision Jun 17, 2026, newest Jun 17, 2026
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "RIVOS EUS Access"
MAUDE reports
0
Brand "RIVOS EUS Access", since 2015
PubMed studies
0
Mentioning "RIVOS EUS Access"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing RIVOS EUS Access Device (M00553900)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260428 · Decided Jun 17, 2026 · 127 days after receipt
Device type: Endoscopic Ultrasound System, Gastroenterology-Urology (ODG) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "RIVOS EUS Access", any status and sponsor, newest update first.
Orlando Health, Inc.Academic, hospital or other
NCT07696572 · 30 participants (planned) · Start Jul 13, 2026 · Primary completion Jul 2027
Device: EUS-guided intervention using the RIVOS™ EUS access device · For: Pancreatic Fluid Collections; Biliary Obstruction; Pancreatic Duct Obstruction and 2 more
Sites: Orlando, Florida
- RIVOS Feasibility (MBO)Withdrawn
Boston Scientific CorporationPublic (BSX)
NCT06666699 · 0 participants · Start Aug 31, 2025 · Primary completion May 30, 2026
Device: EUS access device · For: Malignant Biliary Obstruction
Sites: Ghent, Belgium; Paris, France; Hyderabad, India
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RIVOS EUS Access", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code ODG
18,417 reports: 18,068 malfunction, 314 injury, 32 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "RIVOS EUS Access"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code ODG.
- PENTAX Medical Ultrasound Upper GI Video Scope EG34-J10UPentax of America, Inc. · 510(k) 2020
- Expect Slimline (SL) Endoscopic Ultrasound Aspiration NeedleBoston Scientific · 510(k) 2017
- EVIS EUS Ultrasound Gastrointestinal Videoscope (Olympus GF-UE190)Olympus Medical Systems Corporation · 510(k) 2026
- FUJIFILM Ultrasonic Endoscope EG-740UTFujifilm Corporation · 510(k) 2022
- Expect Endoscopic Ultrasound Aspiration NeedleBoston Scientific Corporation · 510(k) 2011
- EG-3670URKPentax Medical Company · 510(k) 2009
- EG-3830UT, Video Ultrasound GastroscopePentax Precision Instrument Corp. · 510(k) 2003
- FG-36UX Fiber Ultrasound GastroscopePentax Precision Instrument Corp. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.